NCT04679376 - Statins for the Treatment of NASH | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG

Atorvastatin

40 mg daily administered orally in tablet or capsule form

DRUG

Placebo

Administered daily orally in tablet or capsule form, contains no active medicine

Trial Locations (2)

ACTIVE_NOT_RECRUITING

Duke University Medical Center, Durham

RECRUITING

Mayo Clinic Minnesota, Rochester